Latest / Pharmacy Podcast Network / The Future of Pharmacy Where Next for the Profession | Love Your Pharmacist Awards presented by Clinigen
Transcript
- 0:05Speaker 1: You are listening to the Global Network of Podcasters dedicated
- 0:09Speaker 1: to the pharmacy profession.
- 0:10Speaker 2: Welcome to the Pharmacy Podcast Network.
- 0:31Speaker 3: Welcome to the second episode of our special podcast series,
- 0:35Speaker 3: celebrating hospital pharmacy in partnership with Clinigin's Love Your Pharmacist Awards.
- 0:41Speaker 3: Today's episode is dedicated to World Pharmacist Day. World Pharmacist
- 0:46Speaker 3: Day is an opportunity to recognize the expertise, dedication, and
- 0:50Speaker 3: impact of pharmacists across healthcare. Every day, pharmacists help patients
- 0:55Speaker 3: navigate increasingly complex treatment journeys, support multidisciplinary healthcare teams, and
- 1:00Speaker 3: apply clinical expertise to improve outcomes. Today, we're joined by
- 1:04Speaker 3: Karel Bauer, who began his career as a pharmacist and
- 1:08Speaker 3: is now Managing Director for Clinigens Africa Region. and Nicolene Shoman,
- 1:13Speaker 3: dispensary manager at Zoued Africans Hospital in South Africa.
- 1:17Speaker 4: Hey, it's World Pharmacist Day, Pharmacy Podcast Network, and our
- 1:23Speaker 4: entire crew. Shout out to our producer, Brady, and Tyler,
- 1:27Speaker 4: and Andrea. I want to thank you for your work.
- 1:30Speaker 4: And then I want to shout out to our pharmacist today,
- 1:33Speaker 4: and what better way to do it In an international celebration,
- 1:37Speaker 4: I would like to introduce my guests, Karel Bauer, who
- 1:42Speaker 4: began his career as a pharmacist and is now managing
- 1:45Speaker 4: director for Clinigens Africa region, and Nicolene Shoman, the dispensary
- 1:52Speaker 4: manager at ZooEd Africans Hospital in South Africa. Karel, welcome
- 1:59Speaker 4: to the show.
- 2:01Speaker 5: Good morning, Todd.
- 2:02Speaker 1: Thank you very much and happy World Pharmacist Day to
- 2:05Speaker 1: all the pharmacists out there. It's a real pleasure to
- 2:08Speaker 1: join the podcast today and we look forward to contribute
- 2:11Speaker 1: and give a little bit of insights from African perspective
- 2:15Speaker 1: on the effects of pharmacists in the pharmaceutical environment in
- 2:20Speaker 1: Africa and across the rest of the globe.
- 2:23Speaker 4: Thank you so much. And Over to Nikki, introduce yourself
- 2:28Speaker 4: to the listeners and where are you in the world
- 2:31Speaker 4: right now?
- 2:33Speaker 2: Thank you so much for this opportunity.
- 2:35Speaker 6: I'm Nikudine Skuman, as I'm called Nikki by a lot
- 2:38Speaker 6: of people, and I work at South Africa Hospital Pharmacy
- 2:42Speaker 6: in Pretoria. So I know Pretoria for you might not
- 2:46Speaker 6: mean a lot, but it is one of the capital
- 2:49Speaker 6: cities of South Africa. We're actually known as the administrative city.
- 2:53Speaker 6: So we have a lot of the embassies from all
- 2:55Speaker 6: over the world. So our union buildings.
- 2:59Speaker 2: So the hospital that.
- 3:00Speaker 6: I'm working at, South Afrikaans, has a very rich, long
- 3:03Speaker 6: history in South Africa. It was established in 1904 already
- 3:08Speaker 6: during the Anglo-Buddha war, which I'm sure you guys have
- 3:13Speaker 6: learned about in history classes in school. And yeah, it's
- 3:17Speaker 6: just been built up from there. It started with 2010.
- 3:21Speaker 6: And we are now at almost 200 beds and really
- 3:24Speaker 6: specializing in cardiology and your internal medication a lot. I'm
- 3:30Speaker 6: the dispensary manager, but I actually started out as a
- 3:33Speaker 6: clinical pharmacist here at South Africa for the past five years.
- 3:37Speaker 6: And I've just moved into this new position recently.
- 3:41Speaker 4: You are uncovering so much that people don't realize what
- 3:46Speaker 4: pharmacists actually do. And that brings me to really opening
- 3:51Speaker 4: up this conversation as a celebration on World Pharmacists Day. Karel,
- 3:56Speaker 4: people think, you know, you wear the white lab coat,
- 3:59Speaker 4: you're standing behind the counter in the retail space, in
- 4:04Speaker 4: the community space. What is one thing you wish more
- 4:07Speaker 4: people understood about what pharmacists actually do?
- 4:10Speaker 5: Great question.
- 4:13Speaker 1: I think something, you know, often get asked by my
- 4:16Speaker 1: friends and would like to explain that A pharmacist is
- 4:19Speaker 1: not just an expert of medicines, but we are part
- 4:23Speaker 1: of a whole patient journey, understanding what a patient needs,
- 4:26Speaker 1: but also the whole development of a pharmaceutical molecule, clinical trials,
- 4:32Speaker 1: testing through the regulatory process, and then eventually to making
- 4:36Speaker 1: that product available for different supply, logistical routes and regulatory
- 4:40Speaker 1: processes and navigating complex environments to essentially get a medicine
- 4:45Speaker 1: to a patient.
- 4:46Speaker 5: And supporting that patient throughout.
- 4:48Speaker 1: His journey to ensure he gets the best possible treatment
- 4:52Speaker 1: and get the best possible results for whatever disease he
- 4:56Speaker 1: needs to get treated. So I think it's understanding that
- 4:58Speaker 1: whole context of the whole value chain of the pharmaceutical product,
- 5:04Speaker 1: but also of the patient journey that a pharmacist is
- 5:07Speaker 1: involved in all of the different steps that really makes
- 5:10Speaker 1: a medicine come to life. And there's so many aspects
- 5:13Speaker 1: to it that is really essential to essentially seeing a
- 5:17Speaker 1: product on the shelves.
- 5:18Speaker 5: At the end of the day.
- 5:20Speaker 4: Nicky, you started off by kind of giving some background
- 5:23Speaker 4: to what you're doing. And I want to open up
- 5:26Speaker 4: kind of the same question. If you thought from an
- 5:30Speaker 4: education perspective for the public, for our administration, for some
- 5:33Speaker 4: of our managers, and even our primary care and physicians
- 5:37Speaker 4: out there, what do you want them to know that
- 5:40Speaker 4: what pharmacists are doing out there?
- 5:43Speaker 6: Yeah, I think I can maybe touch on a couple
- 5:45Speaker 6: of points that Coral said. Although we are in different industries,
- 5:48Speaker 6: I think at the end of the day, it's about
- 5:51Speaker 6: so much more than medicines for us. So for them,
- 5:54Speaker 6: it's about getting the medicine. Yeah, but at the end
- 5:57Speaker 6: of the day, they are looking... at the patient behind
- 5:59Speaker 6: that medication. And that is what it's all about. And
- 6:02Speaker 6: same here in the hospital setting from a hospital clinical
- 6:05Speaker 6: pharmacy side, we do so much more than just pick
- 6:09Speaker 6: medication from the shelf or, you know, count out the tablets.
- 6:12Speaker 6: We are actively involved in looking at the prescriptions, interpreting them,
- 6:17Speaker 6: questioning the dosing, looking at the appropriateness and the indication
- 6:21Speaker 6: and really considering, you know, the patient's individuality, their weight,
- 6:25Speaker 6: their renal function, their liver function, but that is only
- 6:29Speaker 6: one small aspect of it. So we also need medication
- 6:33Speaker 6: in order to serve our patients. So there comes in
- 6:36Speaker 6: stock management, getting stock into the pharmacies, getting it into
- 6:40Speaker 6: the front shop for our chronic patients or outside patients
- 6:43Speaker 6: to buy, getting medication to the wards, to the theatres
- 6:47Speaker 6: so that surgical procedures can happen, getting it into the
- 6:50Speaker 6: emergency charlies if there's emergencies in the units, So we
- 6:55Speaker 6: really do so much more in the background. We are
- 6:58Speaker 6: involved with the TPN ordering, with acquiring medication access like
- 7:03Speaker 6: Section 21s that Coral knows really well. Getting that access
- 7:07Speaker 6: to our patients and their logistics and the administration component,
- 7:12Speaker 6: it's all dependent.
- 7:13Speaker 2: On us in the pharmacy to do that.
- 7:15Speaker 6: And I think at the end of the day, the
- 7:16Speaker 6: patient just sees the medication or they just see it
- 7:19Speaker 6: being administered, but they don't really know the big involvement
- 7:23Speaker 6: that the pharmacist play in making sure it's safe, that
- 7:26Speaker 6: it's there in the first place, and that it's really
- 7:29Speaker 6: optimal for this individual patient themselves.
- 7:32Speaker 4: I love that. So, Karel, imagine you are a pharmacy student,
- 7:38Speaker 4: you go back to university, and you know all of
- 7:43Speaker 4: the opportunities of what's happening today, pharmacogenomics, digging into the
- 7:48Speaker 4: DNA of a patient and knowing how a medication might
- 7:52Speaker 4: affect me versus how it affects you, and clinical trials
- 7:56Speaker 4: and medical science liaisons that work with the pharmaceutical manufacturers.
- 8:01Speaker 4: What would you do or would you join a different
- 8:05Speaker 4: sector or what do you think of where we're at
- 8:09Speaker 4: today and from your eyes as a student?
- 8:13Speaker 1: I think, like you correctly state, the industry has evolved
- 8:17Speaker 1: so much over the past several years. The development of
- 8:22Speaker 1: drugs and the availability of medicines has really evolved. And
- 8:26Speaker 1: then the influence of pharmacogenomics, personal medicine, but also AI,
- 8:32Speaker 1: as we see now, and how data really change how
- 8:35Speaker 1: a pharmacist can interpret data.
- 8:38Speaker 5: There's so many aspects, I think, that you would need
- 8:41Speaker 5: to consider. And it's really.
- 8:42Speaker 1: Exciting being in this field and being in this environment
- 8:45Speaker 1: and getting to see this major change and leaps and
- 8:48Speaker 1: bounds that the and that the medical industry and the
- 8:52Speaker 1: healthcare industry is taking over a short period of time.
- 8:56Speaker 5: So from my perspective.
- 8:57Speaker 1: There's a lot of different aspects that I would have
- 9:00Speaker 1: focused on and I would think pharmacy schools would need
- 9:02Speaker 1: to develop future pharmacists to be future-proof and that there's understanding,
- 9:07Speaker 1: interpreting AI data, because we know that's going to play
- 9:10Speaker 1: a large part, but the pharmacist is going to be
- 9:12Speaker 1: so essential in having the guardrails of that data, making
- 9:16Speaker 1: sure that you have the personal interaction to treat a
- 9:19Speaker 1: patient with the correct medicine, understanding, you know, what the
- 9:23Speaker 1: human factor behind that is, but also developing in all
- 9:26Speaker 1: of the different sectors, you know, from developing drugs, clinical
- 9:30Speaker 1: trial space, and then, you know, how.
- 9:31Speaker 5: That evolve through quality aspects of a medicine.
- 9:34Speaker 1: Pharmacovigilance we see is really becoming a major part of
- 9:39Speaker 1: a medicine, understanding what impact the medicine could have after
- 9:42Speaker 1: it is on the market and, you know, how do
- 9:44Speaker 1: you continue to develop and work on the safety, efficacy
- 9:47Speaker 1: and quality of a product is where pharmacy is going
- 9:50Speaker 1: to be essential in the future of a product. And then,
- 9:54Speaker 1: getting the specific dosing for a patient and understanding how
- 9:58Speaker 1: that patient will interact and how the genetics of the
- 10:00Speaker 1: patient will interact.
- 10:02Speaker 5: It's going to become more and more relevant.
- 10:03Speaker 1: So we've seen a large shift already with pharmacists becoming
- 10:07Speaker 1: a leading part of a multidisciplinary team, implementing antibiotic stewardship.
- 10:13Speaker 1: And I think that's going to continue to evolve in
- 10:16Speaker 1: all different sectors as we go into the future of pharmacists.
- 10:19Speaker 1: So it's going to be really exciting. And there's so
- 10:22Speaker 1: many aspects to focus on. that I think you can
- 10:24Speaker 1: really niche yourself and brand yourself into a different sector
- 10:29Speaker 1: and become a leading expert as we evolve in the
- 10:31Speaker 1: pharmaceutical industry.
- 10:35Speaker 4: I meet with pharmacy students a couple times per year,
- 10:39Speaker 4: and I look at their curriculum, epidemiology and biology and chemistry,
- 10:45Speaker 4: and it makes my head hurt. And they're so packed
- 10:51Speaker 4: with information. These young pharmacists, are so intelligent and they
- 10:56Speaker 4: just know so much. Nikki, when I think of all
- 10:59Speaker 4: of the qualifications and how university prepares our future pharmacists,
- 11:06Speaker 4: it's mind-blowing of what you have to know and what
- 11:09Speaker 4: you have to keep up with. And it saves people's lives.
- 11:12Speaker 4: Pharmacists are almost like these little investigators that are advocating
- 11:18Speaker 4: for the patients and keeping them safe. You're the safety expert.
- 11:22Speaker 4: And you're so brilliantly prepared for what's to come from
- 11:26Speaker 4: an education perspective. But what do you think pharmacists of
- 11:30Speaker 4: today entering any sector of pharmacy, what aren't they prepared for?
- 11:36Speaker 2: Sure.
- 11:37Speaker 6: Yeah, it's a very difficult question actually to answer. I
- 11:40Speaker 6: was in school about 12 years ago when I graduated.
- 11:45Speaker 6: But then during my studies, my bachelor's degree, we were
- 11:50Speaker 6: very focused on pharmacology. So I came out of school,
- 11:54Speaker 6: you know, really knowing pharmacology off by heart. I knew
- 11:57Speaker 6: every single active ingredient. I knew the mechanism of action.
- 12:00Speaker 2: I knew the.
- 12:01Speaker 6: Indication and way to position the drug.
- 12:05Speaker 2: And so I could do that.
- 12:06Speaker 6: And I had some experience working in the pharmacy because
- 12:09Speaker 6: we were made to work hours in a pharmacy.
- 12:11Speaker 2: But when I actually got.
- 12:12Speaker 6: Into real life, now being positioned in a pharmacy, I
- 12:16Speaker 6: had no idea about the business of making pharmacy work.
- 12:21Speaker 6: And so I think that really is still today a
- 12:23Speaker 6: bit of a shortcoming from universities because in South Africa,
- 12:27Speaker 6: you do your bachelor's degree, then you do an internship
- 12:31Speaker 6: and a community service year. And then oftentimes you are
- 12:34Speaker 6: placed into a pharmacy as the only pharmacist, the responsible pharmacist,
- 12:38Speaker 6: and you're about 25 years old. And so now suddenly
- 12:42Speaker 6: you need to start running a business and you have
- 12:45Speaker 6: no experience, you have not been taught about gross profits
- 12:49Speaker 6: with stock evaluation, stock dice. You don't know anything about
- 12:53Speaker 6: people management. And now you have to lead a team
- 12:56Speaker 6: of people who's probably much older than you You know,
- 12:59Speaker 6: think about things like sick leave, like family responsibility, hours
- 13:03Speaker 6: and salaries. And so I think from a practical aspect,
- 13:07Speaker 6: that really is that business acumen is lacking in today's pharmacies.
- 13:11Speaker 4: So I understand there are so many developments coming. There's
- 13:17Speaker 4: new medications coming to the market because the disease, like
- 13:22Speaker 4: oncology and the cancer world, we're starting to become very,
- 13:25Speaker 4: very specific about what medication is being applied. And therefore,
- 13:31Speaker 4: I think of all of the opportunities in becoming a
- 13:34Speaker 4: specialized pharmacist after the basics of your pharmacological education. However,
- 13:42Speaker 4: I'm wondering, during pharmacy school, what do you think if
- 13:48Speaker 4: we were to redesign some of the curriculum, let's say
- 13:51Speaker 4: for the next decade, knowing that the pharmaceutical industry is expanding?
- 13:57Speaker 4: What should they start teaching more of, Karel? What do
- 14:00Speaker 4: you think should be added?
- 14:02Speaker 5: Thank you, Todd.
- 14:02Speaker 1: And looking at it, you're completely right that the industry
- 14:07Speaker 1: is evolving at a rapid pace and there's so much
- 14:10Speaker 1: more that we can do. I think having the basic
- 14:12Speaker 1: knowledge that we are currently taught at pharmacy school, understanding pharmacology, pharmaceutics,
- 14:18Speaker 1: pharmacoeconomics is a really essential part. But then to specialize
- 14:23Speaker 1: in different areas is going to become more and more
- 14:25Speaker 1: relevant in and then focusing on different therapeutic areas is
- 14:29Speaker 1: a real involvement that I think could benefit pharmacists, you know,
- 14:33Speaker 1: as they start to specialize in different areas where they
- 14:36Speaker 1: want to be. We see that, you know, whether it's
- 14:39Speaker 1: a retail pharmacy or whether it's a hospital pharmacy, but
- 14:41Speaker 1: then looking at the therapeutic areas, really understanding the difference of,
- 14:45Speaker 1: you know, oncology, genetics of a patient. And I would
- 14:50Speaker 1: go even further in saying that, you know, there's so
- 14:53Speaker 1: many different operational areas that a pharmacist participate in that
- 14:58Speaker 1: you can really gain additional experience in and be experts.
- 15:02Speaker 1: And that is from the quality aspects to clinical trials
- 15:06Speaker 1: of medicine. So I would say looking at the development
- 15:09Speaker 1: plan of a pharmacy school, it's understanding, you know, how
- 15:13Speaker 1: a pharmacist would specialize in different areas as medical healthcare
- 15:18Speaker 1: professionals currently do.
- 15:19Speaker 5: And then also, you know, interpreting.
- 15:21Speaker 1: Data and really knowing that how should you interpret that
- 15:25Speaker 1: data because it will be ever evolving and you would
- 15:27Speaker 1: see different data being presented to you. You know, in
- 15:31Speaker 1: South Africa, where we are situated, we often see that
- 15:35Speaker 1: navigating regulatory areas, you know, can be really complex and
- 15:39Speaker 1: understanding how that different areas can impact patient care is essential.
- 15:43Speaker 1: So I mean, we're clinically specialized in looking for disease
- 15:47Speaker 1: that's not yet registered or really specialized therapeutic areas.
- 15:51Speaker 5: We look at, you know.
- 15:52Speaker 1: How can we assist in that pharmacist in gaining the
- 15:55Speaker 1: necessary knowledge of understanding that medicine. And then once they required,
- 15:59Speaker 1: you know, having the necessary means to access that medicine. So,
- 16:03Speaker 1: so many aspects of evolving in a pharmacist that can
- 16:07Speaker 1: become really essential as the industry and the profession grows
- 16:11Speaker 1: into the future.
- 16:14Speaker 4: Nikki, in the United States, we have our pharmacists, pharmacy students.
- 16:20Speaker 4: I meet with P3s, third-year students, WVU School of Pharmacy,
- 16:25Speaker 4: and just met with them two weeks ago. When they
- 16:28Speaker 4: hit that third year, they start thinking, do I want
- 16:31Speaker 4: to go into community? Do I want to focus on
- 16:33Speaker 4: senior care? Am I going to go into hospital system
- 16:37Speaker 4: and go into supporting the physicians at the bedside? Then
- 16:43Speaker 4: all of a sudden you get out of pharmacy school
- 16:46Speaker 4: and now you're seeing dermatology becoming huge and you're starting
- 16:50Speaker 4: to see pediatrics starting to become needed and we need pharmacists.
- 16:54Speaker 4: So from your perspective in school, we have the basis
- 16:59Speaker 4: of what it means to become a pharmacist. And that
- 17:03Speaker 4: education is amazing, but it's very intense. And then that pathway,
- 17:07Speaker 4: do I make a decision to spend two, three, and
- 17:10Speaker 4: four more years in a hospital system to become hospital
- 17:14Speaker 4: system pharmacist, or do I move to specialty? Do you
- 17:17Speaker 4: think we should expand education to start giving our new
- 17:21Speaker 4: pharmacists more information in a specialty area?
- 17:27Speaker 6: Yes. I definitely think that like Laurel, as I said,
- 17:30Speaker 6: and you said, it is the way that the world
- 17:33Speaker 6: is evolving to in this profession, especially And it is
- 17:36Speaker 6: also that the curriculum is already very packed and very full.
- 17:40Speaker 6: So it's almost difficult to think that they should now,
- 17:43Speaker 6: on top of just getting the basic education to become
- 17:46Speaker 6: a proper pharmacist or qualified pharmacist, now also learn specialities.
- 17:52Speaker 2: So I think exposure.
- 17:54Speaker 6: During the curriculum is a good idea. Some exposure to
- 17:58Speaker 6: the different specialities, you know, whether it's infectious disease or
- 18:02Speaker 6: emergency medicines or oncology or you know, logistics and importing
- 18:08Speaker 6: can be of worth because then you already get a
- 18:10Speaker 6: feel for, you know, what can I do one day?
- 18:13Speaker 6: Where is my interest? You know, what do I think
- 18:16Speaker 6: I can really contribute to in which industry? But I
- 18:19Speaker 6: think subspecialising would be a postgraduate degree, you know, whether
- 18:25Speaker 6: it's a full degree, master's degree, or maybe just doing
- 18:29Speaker 6: extra additional qualifications, diplomas in special... specialities can also be
- 18:35Speaker 6: of benefit. I know, for example, with the medical practitioners,
- 18:41Speaker 6: they do a lot of extra diplomas, HIV, gastroenterology, whatever
- 18:45Speaker 6: they have an interest in. So I don't think it
- 18:47Speaker 6: necessarily has to be a specific degree, additional master's degree,
- 18:52Speaker 6: but there is room for it. And I think it
- 18:54Speaker 6: is a place where pharmacists can continue to be the
- 18:57Speaker 6: experts in medication and as Times are evolving and we
- 19:01Speaker 6: are getting more and more complex cases out there. There
- 19:05Speaker 6: really is a place that we can position ourselves to
- 19:08Speaker 6: be specialists in certain areas.
- 19:12Speaker 5: I agree. I like that.
- 19:14Speaker 4: And I think of the work across different healthcare systems,
- 19:20Speaker 4: not only the systems and the specialities, like you said,
- 19:25Speaker 4: like Children's Hospital, for example, and how pharmacists in the
- 19:28Speaker 4: children's space, in the pediatric space, that is so different
- 19:32Speaker 4: than caring for fully grown adults. And so, Karel, what
- 19:38Speaker 4: do the strongest healthcare systems understand about pharmacists that maybe
- 19:43Speaker 4: others don't?
- 19:46Speaker 1: I've been lucky enough to travel to different areas and
- 19:51Speaker 1: working in stronger and more regulated countries. But I think
- 19:56Speaker 1: essentially when you look at the healthcare sector, Most of
- 20:00Speaker 1: those industries really understand the value that the pharmacist can
- 20:03Speaker 1: add in being on the forefront of patient care, but
- 20:08Speaker 1: being part of a multidisciplinary team and then really valuing
- 20:11Speaker 1: a pharmacist's input, going to a pharmacist. asking them what
- 20:17Speaker 1: questions and what the value would be, but also then
- 20:21Speaker 1: understanding how that pharmacy will be an expert in the
- 20:25Speaker 1: whole pharmaceutical and the whole multidisciplinary team. So I think
- 20:29Speaker 1: it's really being the focus on having the pharmacist being
- 20:33Speaker 1: a valuable part of the team and really celebrating a
- 20:37Speaker 1: pharmacist and expertise.
- 20:40Speaker 4: That makes sense. I think of our hospital system pharmacists
- 20:45Speaker 4: and the health system itself becomes the reputation of many
- 20:52Speaker 4: of these systems become experts in specific things. And they're
- 20:56Speaker 4: attracting pharmacists not only from our country, but all over
- 21:00Speaker 4: the world as specialists. And the consultation with the world
- 21:06Speaker 4: in expansion of telehealth has been like, that pharmacist may
- 21:10Speaker 4: be across the world as a specialist in something that
- 21:14Speaker 4: is like cell and gene therapy or biosimilars or something
- 21:18Speaker 4: that is becoming much bigger in leverage of patient care. Nikki,
- 21:26Speaker 4: but what about a hospital perspective? Where do pharmacists make
- 21:30Speaker 4: the biggest difference that patients rarely see? Because our providers
- 21:35Speaker 4: to providers and our nurses and our pharmacists, they see
- 21:38Speaker 4: things differently than, than what our patients do.
- 21:43Speaker 6: Yeah. So I think the hospital pharmacist really makes a
- 21:46Speaker 6: difference in, in, you know, enforcing guidelines in doing dosing
- 21:50Speaker 6: recommendations and checking if you're with you. So South Africa
- 21:54Speaker 6: is a very clinically driven hospital. So we, actually evaluate
- 21:58Speaker 6: every single prescription in pharmacy with the latest guidelines.
- 22:02Speaker 2: We use international guidelines.
- 22:04Speaker 6: To make sure our patient is receiving optimal dosing of
- 22:07Speaker 6: whatever medication is being prescribed. Because in South Africa, for example,
- 22:11Speaker 6: our medication is registered at Zafra. and it might have
- 22:16Speaker 6: been registered 10 or 20 years ago, and so the
- 22:18Speaker 6: package insert will say a certain dose. But as if
- 22:21Speaker 6: we think about antimicrobials, as resistance has evolved and gotten
- 22:25Speaker 6: worse and worse, those doses just actually go higher and higher,
- 22:29Speaker 6: and it's not necessarily reflecting in the South African guidelines.
- 22:33Speaker 6: So we are very focused on enforcing international dosing guidelines,
- 22:37Speaker 6: checking the patient's individual factors, you know, their weight, whether
- 22:41Speaker 6: they– It's a lipophilic agent that we need to consider
- 22:45Speaker 6: fat distribution of the medication or it's hydrophilic. Are we
- 22:48Speaker 6: not perhaps overdosing in this patient using a hydrophilic molecule?
- 22:53Speaker 6: We look at their renal function, you know, the type
- 22:55Speaker 6: of dialysis that they are receiving. Should we be recommending
- 22:58Speaker 6: some dosage adjustments? the liver function, the age. So we
- 23:03Speaker 6: really do a lot before the medication gets administered in hospital.
- 23:07Speaker 6: And I think at the end of the day, the
- 23:09Speaker 6: patient has no idea about the conversations going on with
- 23:12Speaker 6: the doctors and the up and down WhatsApps being sent
- 23:15Speaker 6: and recommendations being made.
- 23:18Speaker 2: And the other.
- 23:18Speaker 6: Aspect where we really play a big role as well
- 23:21Speaker 6: is ensuring access. So a lot of the times things
- 23:24Speaker 6: do go out of stock. And we need to import
- 23:27Speaker 6: via Section 21 or you need to get an alternative recommendation. And,
- 23:32Speaker 6: you know, the patient just sees the medication being put up.
- 23:35Speaker 6: They don't see the whole pathway that was took to
- 23:37Speaker 6: get that medication to them in the first place. So
- 23:40Speaker 6: I think those are two areas where we really make
- 23:43Speaker 6: an incredible impact and a big contribution to the outcome
- 23:47Speaker 6: and safety of the patient and also perhaps cost. And
- 23:50Speaker 6: that's not often seen recognised.
- 23:55Speaker 4: I think of when you're doing things behind the scenes
- 24:01Speaker 4: that the patient doesn't understand, saving lives of catching dosing errors,
- 24:07Speaker 4: of being able to understand a drug-drug interaction and what
- 24:10Speaker 4: the long-term effect on someone's liver or cancer or something
- 24:15Speaker 4: that it's having from that pharmacological perspective. Goodness gracious, it
- 24:21Speaker 4: makes me take a breath. and be like, you're under
- 24:24Speaker 4: so much pressure. And I think, Karel, that pharmacists are
- 24:30Speaker 4: expected to do so much, and it's increasing, and the
- 24:37Speaker 4: expectations and the responsibility. So pharmacists are facing pressure. Health
- 24:43Speaker 4: systems are facing pressure. Are pharmacists being asked to do
- 24:48Speaker 4: more with less?
- 24:51Speaker 5: Absolutely.
- 24:52Speaker 1: But I don't think it's just a pharmacist. I think
- 24:55Speaker 1: it's across the entire healthcare system. We do see that
- 25:00Speaker 1: as the requirements have evolved and as there's different aspects
- 25:06Speaker 1: that has really become part of a pharmacist's day-to-day operations,
- 25:10Speaker 1: there's so much more to consider and so much more
- 25:12Speaker 1: that a pharmacist needs to do not just purely spending
- 25:17Speaker 1: time with the patient and understanding that patient access, but
- 25:20Speaker 1: really navigating a complex patient journey and healthcare journey for
- 25:26Speaker 1: whether it's access of medicines and whether it's how to
- 25:30Speaker 1: really make sure that the patient gets the optimal medicine
- 25:32Speaker 1: at the optimal dose. We've seen in the past that
- 25:36Speaker 1: the pharmacist was always on the forefront of patient interactions
- 25:40Speaker 1: and patients would normally for pharmacists for minor or, you know,
- 25:46Speaker 1: first point of consultations.
- 25:48Speaker 5: But that, you know, is swift over.
- 25:50Speaker 1: The years to having more engagement directed to healthcare professionals.
- 25:55Speaker 1: And a pharmacist playing a really important part in that
- 26:01Speaker 1: part of a patient journey. And I do think that
- 26:05Speaker 1: with healthcare professionals being resource constrained, but having certain data
- 26:12Speaker 1: and more relevant information available to them, a pharmacist can
- 26:17Speaker 1: get back to that part where they can potentially spend
- 26:20Speaker 1: more time with the patient to really understand their journey.
- 26:24Speaker 1: and to make optimal recommendations to a patient. So within
- 26:29Speaker 1: a stressed healthcare environment and, you know, with a patient
- 26:32Speaker 1: and a pharmacist being stretched across different therapeutic areas, across
- 26:37Speaker 1: different sectors of understanding a patient journey and the medication impact,
- 26:43Speaker 1: it is becoming really irrelevant to evolve and to, you know,
- 26:47Speaker 1: specialise in certain areas, but to use everything possible to
- 26:51Speaker 1: navigate that situation.
- 26:53Speaker 4: Yeah. It's a very good point. Nikki, I think you're
- 27:00Speaker 4: in consultation with a GP, you're talking with a family,
- 27:04Speaker 4: you're speaking with a nurse, you go back to labs
- 27:08Speaker 4: and collecting additional data. What do you think of the
- 27:13Speaker 4: health system in the full use of our pharmacist? What
- 27:17Speaker 4: would you say is an untapped potential? Like where Where
- 27:22Speaker 4: aren't they using pharmacists where they should be using pharmacists?
- 27:28Speaker 2: Sure.
- 27:29Speaker 6: Well, I think there's definitely a lot of potential in
- 27:32Speaker 6: pharmacists that aren't being utilized.
- 27:34Speaker 2: And I just think, but with.
- 27:36Speaker 6: Coral said, you know, it is different around the world
- 27:38Speaker 6: in a South African context. Having the patient, having the
- 27:42Speaker 6: pharmacist at the bedside is still a bit of a
- 27:45Speaker 6: funny concept in some places. So we're sitting with the
- 27:49Speaker 6: knowledge of the experience. We have all the access to
- 27:51Speaker 6: all of the guidelines and the dosing and all of that.
- 27:54Speaker 6: But we are often not really involved. We only see
- 27:57Speaker 6: the end and that's where we get involved. So we
- 28:00Speaker 6: end up with the prescription and then our insights start
- 28:03Speaker 6: to matter. Or we see a polypharmacy prescription and then
- 28:08Speaker 6: we start asking questions. But I think the potential that
- 28:11Speaker 6: we have is that we should actually be positioned from
- 28:14Speaker 6: the start. We should be involved from the get-go, you know,
- 28:17Speaker 6: at the patient's bedside, when the patient is admitted, when
- 28:20Speaker 6: the patient is worked up.
- 28:22Speaker 2: And then already should our.
- 28:24Speaker 6: Recommendations and our knowledge and our expertise be taken into
- 28:27Speaker 6: consideration to plan the treatment plan for this patient. And,
- 28:31Speaker 6: you know, if it's a patient with a lot of
- 28:33Speaker 6: comorbidities or chronic medicine management problems, to be there from
- 28:37Speaker 6: the get-go, not to hopefully pick it up at the
- 28:40Speaker 6: end of the line.
- 28:41Speaker 2: So we should be there.
- 28:43Speaker 6: In antimicrobial stewardship committees before every antimicrobial prescription is being
- 28:48Speaker 6: written to be consulted and to give those recommendations on dicing,
- 28:52Speaker 6: on appropriateness, indication, and all the other aspects as well.
- 29:00Speaker 4: Yes. So much potential. On World Pharmacist Day, we are celebrating.
- 29:06Speaker 4: I want to shout out once again to our pharmacists
- 29:09Speaker 4: out there that are working. Maybe you're tired. Maybe you're
- 29:13Speaker 4: feeling burnt out, but you know that there's more to
- 29:16Speaker 4: this and you have so much potential. Write that down.
- 29:20Speaker 4: Start a journal. Do something to bring things to the
- 29:24Speaker 4: surface and share with your colleagues. Share with other people
- 29:27Speaker 4: in your space or your specialty and And you'll be
- 29:31Speaker 4: surprised by pressing and gentle pressing of being able to
- 29:36Speaker 4: do other things with your pharmacist background. It's so important.
- 29:41Speaker 1: All right.
- 29:42Speaker 4: This is our quick fire round. Karel, we're going to
- 29:45Speaker 4: start with you. And the statement is, the future of
- 29:50Speaker 4: pharmacy is, and you get one word. So the future
- 29:53Speaker 4: of pharmacy is?
- 29:55Speaker 5: Right. Right.
- 29:57Speaker 4: I like that one. That's a good answer.
- 29:59Speaker 2: All right.
- 30:01Speaker 4: Okay. Next up, Nikki. Pharmacists should spend less time.
- 30:05Speaker 6: On manual systems that technology can.
- 30:09Speaker 2: Run for us.
- 30:11Speaker 1: Nice.
- 30:11Speaker 4: Great answer in the future of what's going to happen.
- 30:14Speaker 4: I mean, when we look ahead, if it's 10 years
- 30:16Speaker 4: from now and it's 2036, of how AI is going
- 30:20Speaker 4: to really get rid of a lot of that.
- 30:24Speaker 4: Tasks that a pharmacist should not be doing i love
- 30:26Speaker 4: that answer all right correll the profession needs to.
- 30:31Speaker 1: Stop underestimating the value of pharmacist.
- 30:35Speaker 4: Excellent you get a prize good one all right last
- 30:39Speaker 4: one is for nikki the profession needs to start.
- 30:44Speaker 6: Owning our clinical worth and you know demand that seat
- 30:47Speaker 6: at the table that we've already.
- 30:49Speaker 4: Actually earned my gosh that was terrific You get a bonus.
- 30:54Speaker 4: I love that. I want to thank you, Nikki, for
- 30:57Speaker 4: being here with us. The work that you do is
- 31:00Speaker 4: so important. Correll, thank you. And a shout out to
- 31:04Speaker 4: Clinigen for supporting us on World Pharmacist Day with this
- 31:08Speaker 4: podcast and podcast series. If you missed part one, you'll
- 31:11Speaker 4: find it in the show notes, a link to part one.
- 31:14Speaker 4: It was a wonderful interview. Correll and Nikki, I want
- 31:18Speaker 4: to thank you on World Pharmacist Day and every day.
- 31:21Speaker 4: Make sure that you reach out to me. We'll do
- 31:23Speaker 4: other podcasts together. Thank you for being here and thank
- 31:26Speaker 4: you for sharing.
- 31:27Speaker 5: Thank you, Claudia.
- 31:28Speaker 1: And once again, congratulations for all the world pharmacists out there.
- 31:32Speaker 1: And we really hope that you are celebrated, not just
- 31:36Speaker 1: as unseen heroes, but being seen in the forefront of
- 31:40Speaker 1: the pharmaceutical and patient journey.
- 31:44Speaker 4: Nikki, thank you so much for being here. And once again,
- 31:47Speaker 4: thank you for your work in pharmacy care.
- 31:50Speaker 1: Absolutely.
- 31:51Speaker 6: Thank you so much for the opportunity and congratulations on
- 31:53Speaker 6: World Pharmacist Day. As fellow pharmacists, we really know what
- 31:58Speaker 6: every pharmacist is going through out there and the incredible
- 32:00Speaker 6: amount of work that they are putting in. So thank
- 32:03Speaker 6: you for every single pharmacist out there.
- 32:05Speaker 4: Thank you. Thank you. Hey, happy World Pharmacist Day. Once again,
- 32:09Speaker 4: stay tuned. Part three is coming soon here on the
- 32:13Speaker 4: Pharmacy Podcast Network.
- 32:21Speaker 6: Thank you.